India  

"Serum Institute"

Latest news and video coverage curated from trusted media outlets

0
shares
ShareTweetSavePostSend
 
Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia [Video]

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia

After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed..

Credit: Oneindia     Duration: 03:03Published

You Might Like


Sharad Pawar seeks Bharat Ratna for Dr Poonawalla

Former Union minister Sharad Pawar on Wednesday heaped praises on Dr Cyrus Poonawalla, founder of Serum Institute of India (SII), for his work in the field of vaccine production, and demanded that he..
Mid-Day - Published

Meet woman, executive director of Rs 192000 crore company, known for glamorous and stylish life

Natasha Poonawalla, who is enthusiastic about fashion and design. She is currently serving as the executive director of the Serum Institute of India (SII), one of the biggest producers of vaccines..
DNA - Published

Meet Pune's richest man with net worth of Rs 166500 crore, is founder of world's largest pharmaceutical company, he is..

He played a crucial role as the leader of the Serum Institute of India in the large-scale production of the Covishield vaccine amid the Covid-19 pandemic.
DNA - Published

Adar Poonawala's mansion worth Rs 1446 crore

For those not aware of the name, Adar Poonawala is the CEO of Serum Institute of India, a company that achieved great success in vaccine making and distribution during the COVID pandemic.
IndiaTimes - Published

Imposition of tax on subsidies does not constitute 'taking away' of a benefit : Bombay HC; dismisses challenge by Serum Institute

The Bombay High Court dismissed a petition filed by Serum Institute of India Pvt Ltd challenging a 2016 amendment to the Income Tax Act, 2015. The amendment included subsidies, grants, and incentives..
IndiaTimes - Published

Meet man who owns exotic Rolls-Royce collection, cars worth over Rs 100 crore, not Mukesh Ambani, Ratan Tata, Adani

Yohan Poonawalla is son of Zavaray Poonawalla who co-founded biopharmaceuticals firm Serum Institute of India along with his brother Cyrus Poonawalla in 1966. The billionaire also owns private..
DNA - Published

Meet Yohan Poonawalla, Adar Poonawalla's cousin, collector with cars worth over Rs 100 crore, bigger than Mukesh Ambani

Yohan Poonawalla is the Chairman of Poonawalla Engineering Group and El-O- Matic India Pvt Ltd and he is also a shareholder in Serum Institute of India Pvt Ltd and Chairman of Poonawalla Financials Pvt..
DNA - Published

Cyrus Poonawalla: The Son Of A Horse Breeder Who Didn't Follow His Family's Footsteps But Carved His Own Path And Now Has A Net Worth Of Rs 2,25,000 Crore

Cyrus Poonawalla founded the Serum Institute of India (SII) in 1966, which is today the world's largest vaccine manufacturer.
Zee News - Published

Age is just a number, look at Ratan Tata, Bachchan: NCP Lok Sabha member Supriya Sule takes on Ajit Pawar

"Some people are saying that people who are senior now should give us their blessings (and retire). Why should they stop working? Ratan Tata who heads India's largest conglomerate is 86 years old...
IndiaTimes - Published

This man leads India's most valuable unlisted company worth Rs 1.92 lakh crore, not Mukesh Ambani, Ratan Tata, Adani

Adar Poonawalla's Serum Institute of India (SII), which became a household name for developing Covid-19 vaccines, is ranked as India's most valuable unlisted company,
DNA - Published

Bombay HC says content posted against Covishield vaccine prima facie defamatory

The Bombay High Court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and..
Mid-Day - Published

Content posted against Serum Institute of India, its Covishield vaccine prima facie defamatory: Bombay HC

The Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and..
IndiaTimes - Published Also reported by •Mid-Day

A New Beacon of Education - Utkal Gaurav International School Shines Bright in the Remote Village of Berunapadi, Odisha

a new beacon of education - utkal gaurav international school shines bright in the remote village of berunapadi, odisha
Several titans of business, academics, sports, medicine and arts have come together in an unknown village Berunapadi, of Odisha, to commemorate the opening of the Utkal Gaurav International School..
NewsVoir - Published

Serum Institute to double investment in Biocon's unit to $300 million


IndiaTimes - Published

Covovax for adults to reach metros in a week: SII

Serum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four to five days, while a Bharat Biotech..
IndiaTimes - Published

DNA Explainer: What is R21/Matrix-M, Oxford-Serum Institute's 'world-changer' malaria vaccine?

The R21 vaccine, created at Oxford University and approved by the Ghanaian Food and Drugs Authority, is now available to the age group most at risk of malaria-related mortality.
DNA - Published

SII to restart vaccine production amid surge in Covid cases

Serum Institute of India CEO Adar Poonawalla told TOI on Wednesday that the company has resumed production of its Covid-19 vaccine, Covishield, in response to the increasing number of SARS-CoV-2 virus..
IndiaTimes - Published

Serum Institute of India restarts manufacturing of Covid-19 vaccine Covishield

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said the..
IndiaTimes - Published

Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults


IndiaTimes - Published Also reported by •Zee News

ET GrandMasters, an OTT Platform for Business Learning from Top Corporate Leaders of the Country

et grandmasters, an ott platform for business learning from top corporate leaders of the country
India's leading destination for consuming business & economy related news, Economic Times Digital has now launched a new OTT platform called *ET GrandMasters*. *ET GrandMasters, an OTT Platform from..
NewsVoir - Published

Serum Institute to set up CoE for Infectious Diseases and Pandemic Preparedness in Hyderabad


newKerala.com - Published

Serum Institute of India launches first made-in-India HPV vaccine for cervical cancer


newKerala.com - Published Also reported by •IndiaTimes

DGCI approves market authorisation of Serum Institute's Covovax as booster dose


newKerala.com - Published

Drug panel favours nod for Covovax as Covid booster

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have..
IndiaTimes - Published

Covovax may get approval as heterologous booster

The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for..
IndiaTimes - Published

Covid situation in India better than elsewhere: SII CEO Adar Poonawalla

Serum Institute CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic. "Everyone..
IndiaTimes - Published

Covid-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works very well against the..
IndiaTimes - Published

Serum Institute to provide 2 crore Covishield doses to central govt free of cost


IndiaTimes - Published

Adar Poonawallah`s IMPORTANT MESSAGE amid Covid outbreak in China

Amid an alarming surge of Covid-19 cases in China, the CEO and founder of Serum Institute of India Adar Ponawalla in a tweet has urged the people not to panic. Serum Institute of India is the one who..
Zee News - Published

Rising Covid-19 cases in China `concerning`: Serum Institute CEO Adar Poonawalla

We must continue to trust and follow the guidelines set by the Government of India, Serum Institute of India (SII) CEO Adar Poonawalla said as he expressed concern over reports of a rising COVID-19..
Zee News - Published

Biocon Q2FY23 Revenue at Rs. 2,384 Cr., Up 23 percent; Core EBITDA at Rs. 816 Cr., Up 34 percent Gross R&D Spend at Rs. 252 Crore, Up 52 percent

biocon q2fy23 revenue at rs. 2,384 cr., up 23 percent; core ebitda at rs. 816 cr., up 34 percent gross r&d spend at rs. 252 crore, up 52 percent
*Biocon Ltd.* (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the second quarter ended September 30,..
NewsVoir - Published

HPV vaccine production delayed due to Covid focus, will start supply to Indian govt in early 2023: SII

Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on Covid, and will start supplying small quantities of the dose to the Indian government in early 2023,..
IndiaTimes - Published

Get your House Deep Cleaned by HiCare Professionals Today

get your house deep cleaned by hicare professionals today
The art of organizing and cleaning a house is a never-ending process, especially during the festive season. *HiCare* has specialized in professional home cleaning services in India. Responsibilities..
NewsVoir - Published

Fraudsters dupe Serum Institute of over Rs 1 crore by asking for money in CEO Adar Poonawalla`s name

One of the directors of the SII received WhatsApp messages from a person who posed as Adar Poonawalla. The sender asked him to transfer money to certain bank accounts immediately. Believing that it was..
Zee News - Published Also reported by •Mid-DayIndiaTimes

Scammers send fake message in CEO Adar Poonawalla's name, dupe Serum Institute of Rs 1 crore

Fraudsters allegedly attempted to con one of SII's directors by sending him a WhatsApp message asking him to wire money to numerous other accounts.
DNA - Published

Bombay HC issues notice to Central govt, Bill Gates, Serum Institute over plea on alleged Covid vaccine death


IndiaTimes - Published

Cost of cervical cancer vaccine set to be Rs 200-400

Cervavac, India's first indigenously developed vaccine for preventing cervical cancer caused by Human Papilloma Virus (HPV), is likely to be priced between Rs 200-400 per dose, Serum Institute of India..
IndiaTimes - Published

Desi qHPV vaccine against cervical cancer to be launched today

India is all set to launch on Thursday its first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for prevention of cervical cancer. It has been developed by the Serum Institute..
IndiaTimes - Published

US Delegation visits Serum Institute of India in Pune, discusses cooperation on health issues


newKerala.com - Published

Serum Institute working on Omicron-specific vaccine, can be expected in next six months: Adar Poonawalla

MHRA authorised the vaccine in the UK for adult booster doses "after it met safety, quality, and efficacy requirements," the agency stated.
DNA - Published

Serum Institute’s Cervavac to prevent cervical cancer gets DGCI nod


Indian Express - Published

SII gets govt nod to export 32.4 lakh doses of Covovax vaccine to US

The government has allowed Serum Institute of India (SII) to supply 32.4 lakh doses of its Covid-19 jab Covovax under the brand name Nuvaxovid to the US, which will be the first vaccine to be exported..
IndiaTimes - Published

Government panel recommends emergency approval of Serum Institute’s Covovax for 7-11 year age group

 "The Subject Expert Committee of Drugs Controller General Of India (DCGI) has recommended Serum Institute of India`s (SII) vaccine Covovax for children in the age group of 7-11 years," sources..
Zee News - Published


 Page 1  〉